ADM News Alert Archer Daniels Midland Company (ADM) 49.54 11/05/2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 5, 2014 at 5:54 AM

Archer Daniels Midland Company (ADM) 49.54 $ADM

Watch for Archer-Daniels-Midland to Potentially Pullback After Gaining 4.85% Yesterday
Comtex SmarTrend(R) - Tue Nov 04, 4:42PM CST
Archer-Daniels-Midland (NYSE:ADM) traded in a range yesterday that spanned from a low of $48.60 to a high of $49.75. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $47.60 on volume of 5.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ADM: 49.54 (+2.29)

SmarTrend Watching for Potential Pullback in Shares of Archer-Daniels-Midland After 4.85% Gain
Comtex SmarTrend(R) - Tue Nov 04, 4:41PM CST
Archer-Daniels-Midland (NYSE:ADM) traded in a range yesterday that spanned from a low of $48.60 to a high of $49.75. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $47.60 on volume of 5.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ADM: 49.54 (+2.29)

Archer Daniels Beats Q3 Earnings, Misses on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:20AM CST
Archer Daniels Midland Company (ADM) reported better-than-expected adjusted earnings per share for third-quarter 2014.
BG: 87.66 (-0.03), ADM: 49.54 (+2.29), CVGW: 48.73 (+0.22), ANFI: 17.11 (-0.25)

Archer-Daniels-Midland (ADM) Stock Is Gaining Today Following Third Quarter Earnings Beat
at The Street - Tue Nov 04, 9:24AM CST
Archer-Daniels-Midland (ADM) shares are up after the company beat analysts' third quarter earnings estimates but missed revenue expectations.
ADM: 49.54 (+2.29)

ADM beats 3Q profit forecasts
AP - Tue Nov 04, 6:33AM CST
DECATUR, Ill. (AP) — DECATUR, Ill. (AP) — Archer Daniels Midland Co. (ADM) on Tuesday reported profit of $747 million in its third quarter.
ADM: 49.54 (+2.29)

ADM Reports Adjusted Third Quarter 2014 Earnings of $0.81 per Share
Business Wire - Tue Nov 04, 6:00AM CST
--Net earnings of $747 million, or $1.14 per share
ADM: 49.54 (+2.29)

Can Disney (DIS) Keep the Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 6:30PM CST
Our proven model shows that The Walt Disney Company (DIS) may beat earnings because it has the right combination of 2 key components.
CST: 37.43 (-0.29), ADM: 49.54 (+2.29), DIS: 90.35 (-1.36), KORS: 71.42 (-6.57)

Archer Daniels' Unit Buys Harrell Nut, Changes Name - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 6:00PM CST
Golden Peanut Company LLC, a subsidiary of Archer Daniels Midland Company (ADM), completed the acquisition of some assets and the processing facilities of Harrell Nut Company.
ADM: 49.54 (+2.29), CVGW: 48.73 (+0.22), ANFI: 17.11 (-0.25)

Will CBS Corp. (CBS) Miss Q3 Earnings on Weaker Ad Trends? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 5:00PM CST
Our proven model does not conclusively project CBS Corporation (CBS) as likely to beat earnings this quarter.
CST: 37.43 (-0.29), ADM: 49.54 (+2.29), KORS: 71.42 (-6.57), CBS: 51.99 (-2.44)

3 Reasons Why General Mills Isn't Quite a Top Dividend Stock
Dan Caplinger, The Motley Fool - Motley Fool - Mon Nov 03, 8:00AM CST
Source: General Mills. Dividend investors love companies that have loyal customers to provide reliable revenue and income, and food giant General Mills is a great example of how such a company can end up rewarding its long-term shareholders....
ADM: 49.54 (+2.29), SYY: 37.36 (-0.13), GIS: 52.86 (+0.20)

Why Earnings Season Could Be Great for Archer-Daniels (ADM) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:30AM CST
Investors are always looking for stocks that are poised to beat at earnings season and Archer-Daniels may be one such company as the firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
ADM: 49.54 (+2.29)

FDA Says Antifreeze Ingredient Propylene Glycol Is Safe to Eat - Have You Had Your Fill Today?
Rich Duprey, The Motley Fool - Motley Fool - Sat Nov 01, 9:00AM CDT
Antifreeze apparently isn't as appetizing in our radiator as when its components end up in our food and drink. Photo: Wikimedia Commons via EvelynGiggles Mmmmm! Antifreeze. Sounds yummy, no? Well, the Food and Drug Administration says propylene...
ADM: 49.54 (+2.29), MCD: 94.47 (+0.86), DOW: 47.58 (-1.55)

Will Office Depot (ODP) Miss Earnings Estimates this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:53PM CDT
Our proven model does not conclusively show that Office Depot, Inc. (ODP) is likely to beat earnings estimates this quarter.
CST: 37.43 (-0.29), ADM: 49.54 (+2.29), DIS: 90.35 (-1.36), ODP: 6.33 (+1.26)

Will Twenty-First Century Fox (FOXA) Miss on Q1 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:50PM CDT
Our proven model does not conclusively project Twenty-First Century Fox, Inc. (FOXA) as likely to beat earnings this quarter.
CST: 37.43 (-0.29), ADM: 49.54 (+2.29), FOXA: 33.33 (-1.02), DIS: 90.35 (-1.36)

Will Archer-Daniels (ADM) Earnings Beat Estimates in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:38PM CDT
We expect Archer-Daniels (ADM) to beat expectations when it reports third-quarter 2014 results on Nov 4 before the opening bell.
LB: 74.28 (+1.84), KR: 57.08 (+0.64), ADM: 49.54 (+2.29), BBY: 34.36 (-0.05)

Golden Peanut Changes Name to Golden Peanut and Tree Nuts, Acquires Harrell Nut Company
Business Wire - Fri Oct 31, 3:30PM CDT
Golden Peanut Company LLC, a subsidiary of Archer Daniels Midland Company (NYSE: ADM), announced today that it has acquired the processing facilities and certain assets of the Harrell Nut Company, one of the country's leading processors and shellers of pecans. Reflecting the company's continuing expansion of its product portfolio, Golden Peanut also announced today that it is changing its name to Golden Peanut and Tree Nuts.
ADM: 49.54 (+2.29)

Danger Lurking in Mosaic Stock's Dividend Payout Ratio?
Dan Caplinger, The Motley Fool - Motley Fool - Fri Oct 31, 11:31AM CDT
Source: Mosaic. The last thing dividend investors like to see is a company whose earnings aren't sufficient to cover the amount being paid out to shareholders. In general, the best sign of dividend health is a business that can generate enough net...
ADM: 49.54 (+2.29), CF: 252.47 (-3.63), BHP: 58.94 (+0.24), POT: 32.44 (-0.71), MOS: 43.51 (-0.29)

Average Grade for Q3 Earnings Season - Earnings Preview
Sheraz Mian - ZACKS - Fri Oct 31, 6:31AM CDT
Average Grade for Q3 Earnings Season - Earnings Preview
WFM: 39.80 (-0.15), HLF: 44.26 (-11.64), TSLA: 238.93 (-3.66), ADM: 49.54 (+2.29), S: 5.18 (-1.02), DIS: 90.35 (-1.36), WMT: 77.26 (+0.98), AIG: 53.40 (-0.40), KORS: 71.42 (-6.57), BRK.B: 142.18 (+1.37), PCLN: 1,097.70 (-100.82), HUM: 137.75 (-0.73)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...